Follow
Safiye Aktas
Safiye Aktas
Verified email at deu.edu.tr
Title
Cited by
Cited by
Year
Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way
N Eliyatkın, E Yalçın, B Zengel, S Aktaş, E Vardar
The journal of breast health 11 (2), 59, 2015
3962015
Demonstration of ventricular myocardial extensions into the pulmonary artery and aorta beyond the ventriculo‐arterial junction
CAN Hasdemir, S Aktas, F Govsa, EO Aktas, A Kocak, YT Bozkaya, ...
Pacing and Clinical Electrophysiology 30 (4), 534-539, 2007
1602007
BRCA genes: BRCA 1 and BRCA 2.
U Varol, Y Kucukzeybek, A Alacacioglu, I Somali, Z Altun, S Aktas, ...
apoptosis 13, 19, 2018
1092018
Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Nephrotoxicity
O Tufekci, D Gunes, C Özoğul, E Kolatan, Z Altun, O Yılmaz, S Aktaş, ...
Chemotherapy 55 (6), 451-459, 2009
652009
Protective effect of acetyl‐l‐carnitine against cisplatin ototoxicity: role of apoptosis‐related genes and pro‐inflammatory cytokines
Z Altun, Y Olgun, P Ercetin, S Aktas, G Kirkim, B Serbetcioglu, N Olgun, ...
Cell proliferation 47 (1), 72-80, 2014
592014
Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity
D Gunes, G Kirkim, E Kolatan, EA Guneri, C Ozogul, Z Altun, ...
Chemotherapy 57 (3), 186-194, 2011
552011
Sex determination from the sternal end of the rib by osteometric analysis
A Koçak, EÖ Aktas, S Ertürk, S Aktas, A Yemisçigil
Legal Medicine 5 (2), 100-104, 2003
542003
Protective Effects of Acetyl-l-Carnitine on Cisplatin Cytotoxicity and Oxidative Stress in Neuroblastoma
ZS Altun, D Güneş, S Aktaş, Z Erbayrktar, N Olgun
Neurochemical research 35, 437-443, 2010
502010
Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients
Y Olgun, S Aktaş, Z Altun, G Kırkım, DÇ Kızmazoğlu, AP Erçetin, B Demir, ...
International journal of pediatric otorhinolaryngology 90, 64-69, 2016
452016
Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity
Y Olgun, G Kırkım, E Kolatan, M Kıray, A Bagrıyanık, A Olgun, ...
The Laryngoscope 124 (3), 760-766, 2014
422014
Experience of the izmir pediatric oncology group on neuroblastoma: IPOG-NBL-92 protocol
N Olgun, S Kansoy, S Aksoylar, N Cetingul, C Vergin, H Oniz, ...
Pediatric hematology and oncology 20 (3), 211-218, 2003
382003
Is there a gender-related susceptibility for cisplatin ototoxicity?
G Kirkim, Y Olgun, S Aktas, M Kiray, E Kolatan, Z Altun, P Erçetin, ...
European Archives of Oto-Rhino-Laryngology 272, 2755-2763, 2015
372015
Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors
A Chetcuti, S Aktas, N Mackie, C Ulger, G Toruner, M Alkan, D Catchpoole
Pediatric blood & cancer 57 (6), 950-957, 2011
332011
Intercostal Variation for Age Estimation–Are the Standards for the Right 4th Rib Applicable for Other Ribs?
E Özgür Aktas, A Koçak, S Aktas, A Yemisçigil
Collegium antropologicum 28 (2), 267-272, 2004
332004
Expression of stromal caveolin-1 may be a predictor for aggressive behaviour of breast cancer
N Eliyatkin, S Aktas, G Diniz, HH Ozgur, ZY Ekin, A Kupelioglu
Pathology & Oncology Research 24, 59-65, 2018
312018
Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases
G Diniz, S Aktas, C Cubuk, R Ortac, C Vergin, N Olgun
Pediatric Hematology and Oncology 30 (4), 273-284, 2013
302013
Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity
S Bayrak, S Aktaş, Z Altun, Y Cakir, M Tütüncü, S Kum Özşengezer, ...
Journal of International Medical Research 48 (8), 0300060520951393, 2020
292020
Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma
K Yörükoğlu, S Aktas, MU Mungan, Z Kirkali
Urology 53 (4), 684-689, 1999
291999
Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation
IM Frayling, VF Mautner, R Van Minkelen, RA Kallionpaa, S Aktaş, ...
Journal of Medical Genetics 56 (4), 209-219, 2019
282019
Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma
I Agababaoglu, A Önen, AB Demir, S Aktas, Z Altun, H Ersöz, A Sanl, ...
Medicine 96 (6), e5903, 2017
262017
The system can't perform the operation now. Try again later.
Articles 1–20